Dually modified transmembrane proteoglycans in development and disease

This publication has 198 references indexed in Scilit:

• Molecular functions of syndecan-1 in disease
  Matrix Biology, 2012
• Endocardial cell epithelial-mesenchymal transformation requires Type III TGFβ receptor interaction with GIPC
  Cellular Signalling, 2012
• The type III TGF-β receptor betaglycan transmembrane–cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease γ-secretase
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
• Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin
  Oncogene, 2010
• Roles for the type III TGF-β receptor in human cancer
  Cellular Signalling, 2010
• Proteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasion
  Cellular Signalling, 2009
• Genome-wide Association and Follow-Up Replication Studies Identified ADAMTS18 and TGFBR3 as Bone Mass Candidate Genes in Different Ethnic Groups
  The American Journal of Human Genetics, 2009
• Signaling cross-talk between TGF-β/BMP and other pathways
  Cell Research, 2008
• Chondroitin sulphate‐modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas‐mediated pathway
  EMBO Reports, 2008
• Cancer immunoediting: from immunosurveillance to tumor escape
  Nature Immunology, 2002